- $86.57bn
- $91.56bn
- $8.54bn
- 93
- 13
- 84
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,260 | 6,675 | 7,776 | 8,080 | 8,544 |
Cost of Revenue | |||||
Gross Profit | 4,284 | 4,630 | 5,483 | 5,630 | 6,020 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,459 | 4,679 | 5,288 | 5,424 | 5,608 |
Operating Profit | 1,801 | 1,996 | 2,488 | 2,656 | 2,936 |
Net Income Before Taxes | 1,801 | 1,996 | 2,488 | 2,656 | 2,936 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,500 | 1,636 | 2,034 | 2,111 | 2,340 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,500 | 1,638 | 2,037 | 2,114 | 2,344 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,500 | 1,638 | 2,037 | 2,114 | 2,344 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.17 | 3.49 | 4.39 | 4.57 | 5.16 |
Dividends per Share |